Structural basis for the neurotropic AAV9 and the engineered AAVPHP.eB recognition with cellular receptors

por Xu, Guangxue, Zhang, Ran, Li, Huapeng, Yin, Kaixin, Ma, Xinyi, Lou, Zhiyong
Publicado 2022

Rhein antagonizes P2X(7) receptor in rat peritoneal macrophages

por Hu, Fen, Xing, Fulin, Zhu, Ge, Xu, Guangxue, Li, Cunbo, Qu, Junle, Lee, Imshik, Pan, Leiting
Publicado 2015

Divergent engagements between adeno-associated viruses with their cellular receptor AAVR

por Zhang, Ran, Xu, Guangxue, Cao, Lin, Sun, Zixian, He, Yong, Cui, Mengtian, Sun, Yuna, Li, Shentao, Li, Huapeng, Qin, Lan, Hu, Mingxu, Yuan, Zhengjia, Rao, Zipei, Ding, Wei, Rao, Zihe, Lou, Zhiyong
Publicado 2019

Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Co...

por Al Kaabi, Nawal, Yang, Yunkai, Eldin Hussein, Salah, Yang, Tian, Abdalla, Jehad, Wang, Hui, Lou, Zhiyong, Bakkour, Agyad, Arafat, Afnan, Jiang, Zhiwei, Tian, Ye, Xiao, Peng, Zaher, Walid, Eltantawy, Islam, Wang, Chenlong, Xu, Guangxue, Zhang, Yuntao, Yang, Xiaoming
Publicado 2023

APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s Disease pathology

por Chemparathy, Augustine, Guen, Yann Le, Chen, Sunny, Lee, Eun-Gyung, Leong, Lesley, Gorzynski, John, Xu, Guangxue, Belloy, Michael, Kasireddy, Nandita, Tauber, Andrés Peña, Williams, Kennedy, Stewart, Ilaria, Wingo, Thomas, Lah, James, Jayadev, Suman, Hales, Chad, Peskind, Elaine, Child, Daniel D, Keene, C Dirk, Cong, Le, Ashley, Euan, Yu, Chang-En, Greicius, Michael D.
Publicado 2023

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants

por Zhang, Yuntao, Tan, Wenjie, Lou, Zhiyong, Zhao, Yuxiu, Zhang, Jin, Liang, Hongyang, Li, Na, Zhu, Xiujuan, Ding, Ling, Huang, Baoying, Zhou, Weimin, Guo, Yancen, Yang, Zhaona, Qiao, Yuling, He, Zhenyu, Ma, Bo, He, Yao, Zhu, Di, Wang, Zhanhui, Chang, Zhen, Zhao, Xue, Wang, Wei, Xu, Ying, Zhu, Huiqin, Zheng, Xiaotong, Wang, Chenlong, Xu, Guangxue, Wu, Guizhen, Wang, Hui, Yang, Xiaoming
Publicado 2022

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

por Wang, Hui, Zhang, Yuntao, Huang, Baoying, Deng, Wei, Quan, Yaru, Wang, Wenling, Xu, Wenbo, Zhao, Yuxiu, Li, Na, Zhang, Jin, Liang, Hongyang, Bao, Linlin, Xu, Yanfeng, Ding, Ling, Zhou, Weimin, Gao, Hong, Liu, Jiangning, Niu, Peihua, Zhao, Li, Zhen, Wei, Fu, Hui, Yu, Shouzhi, Zhang, Zhengli, Xu, Guangxue, Li, Changgui, Lou, Zhiyong, Xu, Miao, Qin, Chuan, Wu, Guizhen, Gao, George Fu, Tan, Wenjie, Yang, Xiaoming
Publicado 2020

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

por Xia, Shengli, Zhang, Yuntao, Wang, Yanxia, Wang, Hui, Yang, Yunkai, Gao, George Fu, Tan, Wenjie, Wu, Guizhen, Xu, Miao, Lou, Zhiyong, Huang, Weijin, Xu, Wenbo, Huang, Baoying, Wang, Huijuan, Wang, Wei, Zhang, Wei, Li, Na, Xie, Zhiqiang, Ding, Ling, You, Wangyang, Zhao, Yuxiu, Yang, Xuqin, Liu, Yang, Wang, Qian, Huang, Lili, Yang, Yongli, Xu, Guangxue, Luo, Bojian, Wang, Wenling, Liu, Peipei, Guo, Wanshen, Yang, Xiaoming
Publicado 2021

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

por Xia, ShengLi, Zhang, YunTao, Wang, YanXia, Wang, Hui, Yang, YunKai, Gao, George Fu, Tan, WenJie, Wu, GuiZhen, Xu, Miao, Lou, ZhiYong, Huang, WeiJin, Xu, WenBo, Huang, BaoYing, Wang, Wei, Zhang, Wei, Li, Na, Xie, ZhiQiang, Zhu, Xiujuan, Ding, Ling, You, WangYang, Zhao, YuXiu, Zhao, Jun, Huang, LiLi, Shi, XueZhong, Yang, YongLi, Xu, GuangXue, Wang, WenLing, Liu, PeiPei, Ma, Meng, Qiao, YuLing, Zhao, SuHua, Chai, JingJing, Li, QinQin, Fu, Hui, Xu, Ying, Zheng, XiaoTong, Guo, WanShen, Yang, XiaoMing
Publicado 2022